HOME | Career | Contact us
Medical Practitioners > Hepatic disorders > Ursomax Tab
Ursomax Tab
Composition: Each uncoated  tablet contains: Ursodeoxycholic Acid (Ursodiol ) USP 150 mg / 300 mg.

Indications: Cholestatic jaundice, Primary Biliary Cirrhosis, Primary Sclerosing Cholangitis,Jaundice associated with NASH/NAFLD, Gallstone prevention, Gallstone dissolution, Hepatitis.

Contraindications: Hypersensitivity to any component of this product, peptic ulcers or inflammatory diseases of the small intestine and colon,Calcified and pigment stones.

Adverse events: Diarrhea,dyspepsia, chest pain, hypertension, swelling, skin rash, and itching.

Precautions: Discontinue Ursomax if liver function tests show high levels.

Dosage: In cholestatic jaundice: 13-15 mg/kg/day in 2-4 divided doses. In jaundice associated with NASH/NAFLD: 12-15mg/kg/day for 6-12 months.In gall stone dissolution: 6-12 mg/kg/day in 2-3 divided doses. In gall stone prevention: 600mg/day (300mg b.i.d). (For detailed information please write to Zuventus Healthcare Limited, 5119, 5th floor, D-Wing, Oberoi Garden Estates, Chandivali, Andheri (E), Mumbai 400 072 or email to medico@zuventus.com).

© 2013. All Rights Reserved. Zuventus HealthCare Ltd.